Clinilabs chosen for COPD trial

Wednesday, April 27, 2011 02:34 PM

CRO Clinilabs, a company that provides early-stage and clinical drug development services, has been selected to conduct a phase I clinical research study of an investigational medication in patients with chronic obstructive pulmonary disease (COPD).

This is Clinilabs’ third clinical trial examining drug effects in patients with COPD.  “As a specialty CRO, it is exciting to grow our franchise in respiratory disorders as we expand our expertise to an ever wider range of conditions” states Barbara Smallwood, vice president of business development at Clinilabs.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs